Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Christina Messiou"'
Publikováno v:
Clinical Radiology. 76:715-727
Whole-body magnetic resonance imaging (MRI) is now a crucial tool for the assessment of the extent of systemic malignant bone disease and response to treatment, and forms part of national and international recommendations for imaging patients with my
Publikováno v:
Magnetic Resonance Imaging. 75:60-64
Diagnosis of patients suspected of multiple myeloma requires a combination of serological and biochemical tests, bone marrow aspirate (BMA) and/or bone marrow trephine (BMT) biopsies as well as complementary information provided by whole-body cross-s
Autor:
Kabir Mohammed, Myles Smith, David Mansfield, Hayden Snow, Christina Messiou, Stephen Hazell, Emma Davies, David Nicol, Stephanie O'Neill, Nabil Hujairi, Kevin J. Harrington, Nicholas Francis
Publikováno v:
Journal of Cutaneous Pathology. 47:1115-1122
Background Prostate-specific membrane antigen (PSMA) is a prostatic epithelial protein that is used as a radiotracer (68Ga-PSMA-11) for prostate cancer staging. PSMA-PET/CT (positron emission tomography/computed tomography) performed for prostate can
Autor:
James Croft, Kate Downey, Martin Kaiser, Kevin Boyd, Marianne Usher, Christina Messiou, Dow-Mu Koh, Matthew D. Blackledge, Angela Riddell
Publikováno v:
Cancer Imaging, Vol 20, Iss 1, Pp 1-7 (2020)
Cancer Imaging
Cancer Imaging
Background Whole body magnetic resonance imaging (MRI) is now incorporated into international guidance for imaging patients with multiple myeloma. The aim of this study was to investigate inter-observer agreement of triple reported baseline whole-bod
Autor:
Hayden Snow, Christina Messiou, Andrew J. Hayes, Myles Smith, O Sjokvist, Khin Thway, Dirk C. Strauss, L Cairncross
Publikováno v:
British Journal of Surgery. 106:1794-1799
Deep lipomatous tumours can be benign lipomas or intermediate/locally recurring atypical lipomatous tumours (ALTs). Differentiating between these two entities clinically and radiologically is difficult. The aims of this study were to report a series
Autor:
Benjamin Moulin, Winan J. van Houdt, Dirk C. Strauss, Piotr Rutkowski, Amandine Crombé, Alessandro Gronchi, Peter Hohenberger, Sylvie Bonvalot, Michèle Kind, Christina Messiou
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 48(3)
Fat-containing tumors are very commonly found in daily practice with benign lipoma accounting for the majority of superficial tumors. Overlap in imaging findings between benign and intermediate or malignant fat-containing tumor is common. Guidelines
Autor:
Susan Lalondrelle, Gigin Lin, Reza Kalantar, Jessica M. Winfield, Christina Messiou, Dow-Mu Koh, Matthew D. Blackledge
Publikováno v:
Diagnostics, Vol 11, Iss 1964, p 1964 (2021)
Diagnostics
Diagnostics
The recent rise of deep learning (DL) and its promising capabilities in capturing non-explicit detail from large datasets have attracted substantial research attention in the field of medical image processing. DL provides grounds for technological de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::424e6c03d100bca3732682d409a18042
Autor:
Alexandra Renn, Dow-Mu Koh, Christina Messiou, Matthew D. Blackledge, Kate Downey, Aslam Sohaib, Susan Lalondrelle, Jessica M. Winfield, Arash Latifoltojar, Reza Kalantar
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundComputed tomography (CT) and magnetic resonance imaging (MRI) are the mainstay imaging modalities in radiotherapy planning. In MR-Linac treatment, manual annotation of organs-at-risk (OARs) and clinical volumes requires a significant clinic
Autor:
Hind Saffar, Martin Kaiser, Kevin Boyd, Siraj Yusuf, Angela Riddell, Christina Messiou, Alta Y T Lai, Tara Barwick, Andrea Rockall, Dow-Mu Koh
Publikováno v:
European Radiology
Objectives Whole-body MRI (WB-MRI) is recommended by the International Myeloma Working Group for all patients with asymptomatic myeloma and solitary plasmacytoma and by the UK NICE guidance for all patients with suspected myeloma. Some centres unable
Autor:
Marius E. Mayerhoefer, Anton Staudenherz, Stephen J. Archibald, Heiko Schöder, Dominik Berzaczy, Christina Messiou
Publikováno v:
Journal of Magnetic Resonance Imaging
The role of MRI differs considerably between the three main groups of hematological malignancies: lymphoma, leukemia, and myeloma. In myeloma, whole‐body MRI (WB‐MRI) is recognized as a highly sensitive test for the assessment of myeloma, and is